Article
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.
Journal of autoimmunity - 1 Nov 2020
Rodríguez Yhojan, Novelli Lucia, Rojas Manuel, De Santis Maria, Acosta-Ampudia Yeny, Monsalve Diana M, Ramírez-Santana Carolina, Costanzo Antonio, Ridgway William M, Ansari Aftab A, Gershwin M Eric, Selmi Carlo, Anaya Juan-Manuel
Abstract excerpt
Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.